ArticleAmerican health & drug benefits

Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models.

Thomas Lodise et al.PubMed ↗Full text ↗

No numbers read from the abstract.